# NVIDIA and Eli Lilly Commit $1 Billion to Revolutionary AI Drug Discovery Lab

*2026-01-23 01:01 UTC · Technology · 1 min read*

> NVIDIA and Eli Lilly launch $1 billion AI lab to revolutionize drug discovery using advanced computing and digital twins.

NVIDIA and Eli Lilly have announced a $1 billion AI co-innovation lab in San Francisco to transform pharmaceutical research. The five-year partnership will co-locate Lilly scientists with NVIDIA AI engineers to build advanced drug discovery models.

The lab will use NVIDIA BioNeMo platform and Vera Rubin architecture to identify, optimize, and validate new drug molecules at unprecedented speed. Beyond drug discovery, the partnership will apply AI to clinical trials, manufacturing, and supply chain optimization using digital twins built on NVIDIA Omniverse.

"We are putting together a blueprint for what is possible in the future of drug discovery," said Jensen Huang, NVIDIA CEO, at the J.P. Morgan Healthcare Conference where the deal was announced. The partnership builds on Lilly's existing AI factory, which is already the most powerful supercomputer in the pharmaceutical industry.

## Sources

- [nvidianews.nvidia.com](https://nvidianews.nvidia.com/news/nvidia-and-lilly-announce-co-innovation-lab-to-reinvent-drug-discovery-in-the-age-of-ai)
- [bloomberg.com](https://www.bloomberg.com/news/articles/2026-01-12/nvidia-to-invest-1-billion-in-ai-drug-laboratory-with-eli-lilly)

---
TechTools News · https://techtools.cz/tools/news/article/65-nvidia-and-eli-lilly-commit-1-billion-to-revolutionary-ai-drug-discovery-lab
